Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  09 AM Call for Abstracts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 56, 4936-4941, November 1, 1996]
© 1996 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schmelz, E. M.
Right arrow Articles by Merrill, A. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schmelz, E. M.
Right arrow Articles by Merrill, A. H., Jr.

Sphingomyelin Consumption Suppresses Aberrant Colonic Crypt Foci and Increases the Proportion of Adenomas versus Adenocarcinomas in CF1 Mice Treated with 1,2-Dimethylhydrazine: Implications for Dietary Sphingolipids and Colon Carcinogenesis1

Eva M. Schmelz, Dirck L. Dillehay, Sonji K. Webb, Alex Reiter, Jeanette Adams and Alfred H. Merrill, Jr.2

Departments of Biochemistry [E. M. S., A. H. M.], Pathology [D. L. D.], and Chemistry and the Emory Mass Spectrometry Center [A. R., J. A.], and Division of Animal Resources [D. L. D., S. K. W.], Emory University, Atlanta, Georgia 30322

Sphingolipids are hydrolyzed in the gastrointestinal tract to ceramide, sphingosine, and other metabolites that can modulate cell growth, differentiation, and apoptosis. To characterize the effects of dietary sphingolipids on colon carcinogenesis, female CF1 mice were administered 1,2-dimethylhydrazine and then fed an essentially sphingolipid-free diet supplemented with 0 to 0.1% (w/w) sphingomyelin (SM) purified from milk. As was found in a previous pilot study (D. L. Dillehay et al., J. Nutr., 124: 615–620, 1994), SM (@ 0.1%) reduced the number of aberrant colonic crypt foci (by 70%, P < 0.001) and aberrant crypts per focus (by 30%, P < 0.003), which are early indicators of colon carcinogenesis. In longer term studies, SM had no effect on colon tumor incidence or multiplicity; however, up to 31% of the tumors of mice fed SM were adenomas, whereas all of the tumors of mice fed the diet without SM were adenocarcinomas. These findings demonstrate that milk SM suppresses the appearance of more advanced, malignant tumors as well as early markers of colon carcinogenesis. Although the sphingolipid content of foods has not been widely studied, several foods (e.g., milk and soybeans) contain the sphingolipid levels used in these investigations; therefore, this class of compounds could be significant contributors to the cancer preventive effects of some foods.

1 Supported by funds from the National Dairy Board administered in cooperation with the National Dairy Council and National Cancer Institute Grant CA61820.

2 To whom requests for reprints should be addressed, at Department of Biochemistry, 4113 Rollins Research Center, Emory University, Atlanta, GA 30322. Phone: (404) 727-5978; Fax: (404) 727-3954.

Received 7/ 2/96. Accepted 9/ 3/96.




This article has been cited by other articles:


Home page
J DAIRY SCIHome page
R. Rombaut and K. Dewettinck
Thermocalcic Aggregation of Milk Fat Globule Membrane Fragments from Acid Buttermilk Cheese Whey
J Dairy Sci, June 1, 2007; 90(6): 2665 - 2674.
[Abstract] [Full Text] [PDF]


Home page
J DAIRY SCIHome page
R. Rombaut, V. Dejonckheere, and K. Dewettinck
Filtration of Milk Fat Globule Membrane Fragments from Acid Buttermilk Cheese Whey
J Dairy Sci, April 1, 2007; 90(4): 1662 - 1673.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
E. H. Ahn, C.-C. Chang, and J. J. Schroeder
Evaluation of sphinganine and sphingosine as human breast cancer chemotherapeutic and chemopreventive agents.
Experimental Biology and Medicine, November 1, 2006; 231(10): 1664 - 1672.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
M. Moussavi, K. Assi, A. Gomez-Munoz, and B. Salh
Curcumin mediates ceramide generation via the de novo pathway in colon cancer cells
Carcinogenesis, August 1, 2006; 27(8): 1636 - 1644.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Kono, J. L. Dreier, J. M. Ellis, M. L. Allende, D. N. Kalkofen, K. M. Sanders, J. Bielawski, A. Bielawska, Y. A. Hannun, and R. L. Proia
Neutral Ceramidase Encoded by the Asah2 Gene Is Essential for the Intestinal Degradation of Sphingolipids
J. Biol. Chem., March 17, 2006; 281(11): 7324 - 7331.
[Abstract] [Full Text] [PDF]


Home page
J DAIRY SCIHome page
I. Sodini, P. Morin, A. Olabi, and R. Jimenez-Flores
Compositional and Functional Properties of Buttermilk: A Comparison Between Sweet, Sour, and Whey Buttermilk
J Dairy Sci, February 1, 2006; 89(2): 525 - 536.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
S. C Larsson, L. Bergkvist, and A. Wolk
High-fat dairy food and conjugated linoleic acid intakes in relation to colorectal cancer incidence in the Swedish Mammography Cohort
Am. J. Clinical Nutrition, October 1, 2005; 82(4): 894 - 900.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
L. Di Marzio, A. Di Leo, B. Cinque, D. Fanini, A. Agnifili, P. Berloco, M. Linsalata, D. Lorusso, M. Barone, C. De Simone, et al.
Detection of Alkaline Sphingomyelinase Activity in Human Stool: Proposed Role as a New Diagnostic and Prognostic Marker of Colorectal Cancer
Cancer Epidemiol. Biomarkers Prev., April 1, 2005; 14(4): 856 - 862.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
S. S. Castillo and D. Teegarden
Sphingosine-1-Phosphate Inhibition of Apoptosis Requires Mitogen-Activated Protein Kinase Phosphatase-1 in Mouse Fibroblast C3H10T1/2 Cells
J. Nutr., November 1, 2003; 133(11): 3343 - 3349.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
T. Sugawara, M. Kinoshita, M. Ohnishi, J. Nagata, and M. Saito
Digestion of Maize Sphingolipids in Rats and Uptake of Sphingadienine by Caco-2 Cells
J. Nutr., September 1, 2003; 133(9): 2777 - 2782.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
R.-D. Duan, Y. Cheng, G. Hansen, E. Hertervig, J.-J. Liu, I. Syk, H. Sjostrom, and A. Nilsson
Purification, localization, and expression of human intestinal alkaline sphingomyelinase
J. Lipid Res., June 1, 2003; 44(6): 1241 - 1250.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
I. Silins, M. Nordstrand, J. Hogberg, and U. Stenius
Sphingolipids suppress preneoplastic rat hepatocytes in vitro and in vivo
Carcinogenesis, June 1, 2003; 24(6): 1077 - 1083.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
H. Chung, D. Wu, S. N. Han, R. Gay, B. Goldin, R. E. Bronson, J. B. Mason, D. E. Smith, and S. N. Meydani
Vitamin E Supplementation Does Not Alter Azoxymethane-Induced Colonic Aberrant Crypt Foci Formation in Young or Old Mice
J. Nutr., February 1, 2003; 133(2): 528 - 532.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
E. H. Ahn and J. J. Schroeder
Sphingoid Bases and Ceramide Induce Apoptosis in HT-29 and HCT-116 Human Colon Cancer Cells
Experimental Biology and Medicine, May 1, 2002; 227(5): 345 - 353.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
Y. Cheng, A. Nilsson, E. Tomquist, and R.-D. Duan
Purification, characterization, and expression of rat intestinal alkaline sphingomyelinase
J. Lipid Res., February 1, 2002; 43(2): 316 - 324.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
E. M. Schmelz, M. C. Sullards, D. L. Dillehay, and A. H. Merrill Jr.
Colonic Cell Proliferation and Aberrant Crypt Foci Formation Are Inhibited by Dairy Glycosphingolipids in 1,2-Dimethylhydrazine-Treated CF1 Mice
J. Nutr., March 1, 2000; 130(3): 522 - 527.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
E. M. Schmelz, A. S. Bushnev, D. L. Dillehay, M. C. Sullards, D. C. Liotta, and A. H. Merrill Jr.
Ceramide-{{beta}}-D-Glucuronide: Synthesis, Digestion, and Suppression of Early Markers of Colon Carcinogenesis
Cancer Res., November 1, 1999; 59(22): 5768 - 5772.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
H. Vesper, E.-M. Schmelz, M. N. Nikolova-Karakashian, D. L. Dillehay, D. V. Lynch, and A. H. Merrill Jr.
Sphingolipids in Food and the Emerging Importance of Sphingolipids to Nutrition
J. Nutr., July 1, 1999; 129(7): 1239 - 1250.
[Abstract] [Full Text]


Home page
JAMAHome page
P. R. Holt, E. O. Atillasoy, J. Gilman, J. Guss, S. F. Moss, H. Newmark, K. Fan, K. Yang, and M. Lipkin
Modulation of Abnormal Colonic Epithelial Cell Proliferation and Differentiation by Low-Fat Dairy Foods: A Randomized Controlled Trial
JAMA, September 23, 1998; 280(12): 1074 - 1079.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1996 by the American Association for Cancer Research.